<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00315575</url>
  </required_header>
  <id_info>
    <org_study_id>IA0092</org_study_id>
    <secondary_id>5K23AG024062-02</secondary_id>
    <nct_id>NCT00315575</nct_id>
  </id_info>
  <brief_title>Memory Imaging of Normal Aging</brief_title>
  <official_title>BOLD and Perfusion fMRI of Alzheimer's Disease Risk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institute on Aging (NIA)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to develop imaging techniques that can distinguish functional
      brain changes in people at high risk for dementia years prior to onset of clinical memory
      problems from those with normal changes of aging.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The overall goals of this project are to identify consistent patterns of variance in brain
      function in patients at risk for Alzheimer's Disease by using APOE ε4 as a marker for disease
      risk. The activation Blood Oxygen Level Dependency (BOLD) signal will be compared to both
      resting and activation perfusion signals to assess the variability of cerebral blood flow as
      it relates to the BOLD signal. Each participant will be imaged on a 3T MRI scanner while
      performing an associate episodic memory task.

      A total of 90 individuals will be recruited for this study. Participants will be
      non-demented, right handed, adults with or without at least one APOE ε4 allele. Groups will
      be split as follows: A) ages 25-39: non-ε4 (n=15); B) ages 25-39: +ε4 (n=15); C) ages 40-49:
      non-ε4 (n=15); D) ages 40-49: +ε4 (n=15);.E) ages 50-65: non-ε4: F) ages 50-65: +ε4 (n=15).
      These groups will be matched for mean age, mean years of education, gender distribution, as
      well as the presence or absence of a family history of AD in a first degree relative.

      There will be 2 scanning sessions for each participant. Scan session #1 and Scan session #2
      will be acquired within 2 weeks of each other and will take approximately one hour each.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2005</start_date>
  <completion_date type="Actual">July 2008</completion_date>
  <primary_completion_date type="Actual">July 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>identification of consistent patterns of variance in brain function in subjects at risk for Alzheimer's Disease by using APOE ε4 as a marker for disease risk</measure>
    <time_frame>single time point</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Alzheimer's Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Individuals with high risk for Alzheimer's disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Individuals with low risk for Alzheimer's disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>BOLD and Perfusion brain MRI</intervention_name>
    <description>Blood oxygenation and perfusion functional MRI performed twice, two weeks apart; each scan lasts 1 hour</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        healthy adults from the community
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Right-handed

        Exclusion Criteria:

          -  Major medical illnesses

          -  History of significant head trauma with residual cognitive deficits

          -  Other neurological or major psychiatric disorders such as schizophrenia, bipolar
             disorder, developmental learning disorder, and alcohol or substance abuse

          -  MRI contra-indications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam Fleisher, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shiley-Marcos Alzheimer's Disease Research Center, University of California, San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, Small GW. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med. 2000 Aug 17;343(7):450-6.</citation>
    <PMID>10944562</PMID>
  </reference>
  <reference>
    <citation>Mayeux R, Ottman R, Tang MX, Noboa-Bauza L, Marder K, Gurland B, Stern Y. Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann Neurol. 1993 May;33(5):494-501.</citation>
    <PMID>8498827</PMID>
  </reference>
  <reference>
    <citation>Fleisher AS, Houston WS, Eyler LT, Frye S, Jenkins C, Thal LJ, Bondi MW. Identification of Alzheimer disease risk by functional magnetic resonance imaging. Arch Neurol. 2005 Dec;62(12):1881-8.</citation>
    <PMID>16344346</PMID>
  </reference>
  <reference>
    <citation>Fleisher A, Grundman M, Jack CR Jr, Petersen RC, Taylor C, Kim HT, Schiller DH, Bagwell V, Sencakova D, Weiner MF, DeCarli C, DeKosky ST, van Dyck CH, Thal LJ; Alzheimer's Disease Cooperative Study. Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol. 2005 Jun;62(6):953-7.</citation>
    <PMID>15956166</PMID>
  </reference>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2006</study_first_submitted>
  <study_first_submitted_qc>April 14, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2006</study_first_posted>
  <last_update_submitted>January 22, 2009</last_update_submitted>
  <last_update_submitted_qc>January 22, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2009</last_update_posted>
  <responsible_party>
    <name_title>Adam Fleisher, MD</name_title>
    <organization>University of California, San Diego</organization>
  </responsible_party>
  <keyword>Dementia</keyword>
  <keyword>brain circulation</keyword>
  <keyword>disease /disorder proneness /risk</keyword>
  <keyword>neuropathology</keyword>
  <keyword>neurophysiology</keyword>
  <keyword>aging</keyword>
  <keyword>apolipoprotein E</keyword>
  <keyword>genotype</keyword>
  <keyword>hemodynamics</keyword>
  <keyword>memory</keyword>
  <keyword>temporal lobe /cortex</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

